Profile | GDS2987 / GI_24308345-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 31.5 | 65 |
GSM215244 | HMVEC_vehicle_rep2 | 0.7 | 2 |
GSM215253 | HMVEC_vehicle_rep3 | 18.9 | 51 |
GSM215254 | HMVEC_atorvastatin_rep1 | 14 | 35 |
GSM215282 | HMVEC_atorvastatin_rep3 | 16.9 | 37 |
GSM215344 | HMVEC_atorvastatin_rep2 | 9.7 | 24 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 4.7 | 10 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 23.6 | 60 |
GSM215295 | HMVEC_SLx2119_rep2 | 12.9 | 26 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 7.4 | 12 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 20.9 | 34 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 10.7 | 19 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 28.4 | 48 |
GSM215330 | Fibroblasts_vehicle_rep1 | 77.2 | 72 |
GSM215331 | Fibroblasts_vehicle_rep2 | 101.4 | 75 |
GSM215332 | Fibroblasts_vehicle_rep3 | 76.4 | 73 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 92.6 | 75 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 82.1 | 73 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 105.4 | 75 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 105.7 | 76 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 76.9 | 73 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 63.5 | 71 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 46.5 | 68 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 87.9 | 74 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 68.6 | 71 |